CAF Approves $720,000 in Research Grants

Funding medical research is one of CAF’s biggest priorities. Our medical research fellowship program has been encouraging and assisting promising researchers for decades; more recently, our grants for translational research in adult thalassemia have allowed us to expand into new areas of concern to the thalassemia community. This year, CAF approved 6 grants in translational […]

Read more

Roll of Beta-Thalassemia Gene Discovered

Researchers from Weill Cornell Medical College may have discovered the precise role of a gene in beta-thalassemia,  The study, entitled “Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in B-thalassemia”  was published in the May 14, 2008 online issue of the journal Blood, the official publication of the American Society of Hematology (ASH). Splenectomy (spleen removal) […]

Read more

Combination Study Halted

The National Heart, Lung and Blood Institute has halted its Cardiac Deferoxamine/L1 Study due to an inability to enroll a sufficient number of patients to provide statistically relevant results. The purpose of the study was to determine whether left ventricular function improves more rapidly with deferoxamine (DFO) and deferiprone (L1) combination therapy than with DFO […]

Read more

Meet Johnny Chou

CAF speaks with Johnny Chou, Clinical Social Worker at Children’s Hospital Los Angeles. What is your official title at Children’s Hospital Los Angeles (CHLA), and can you tell us a little about what you do? I am the Clinical Social Worker that works directly with patients who live with thalassemia and other red blood cell […]

Read more

Secured By miniOrange